9 June 2026
Welcome to the new MedsPaL Tutorial Series launched on the occasion of World IP Day 2025! In this first video, MPP’s Patent Information Officer, Zongyuan Tang, introduces MedsPaL, the Medicines Patent Pool’s free database providing up-to-date information on patents, licences, and data exclusivity for essential medical products and technologies. She explains what exactly MedsPaL covers in terms of medicines, vaccines, and long-acting technologies. You’ll also learn how to perform a basic product search and how to navigate patent results by country, find relevant licence agreements, and check information about data exclusivity. Whether you’re part of a procurement agency or a public health organisation, MedsPaL helps you navigate patent information to support access to medicines.
Explore more at: www.medspal.org
Press and Media
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of innovative medicines and other health technologies for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed health products and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with 23 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, one antiviral treatment for influenza, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada and Coeffient Giving. MPP’s activities in technology transfer are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, the Government of Flanders and SDC.